Related references
Note: Only part of the references are listed.Determination of In Vitro Activities of Solithromycin at Different pHs and Its Intracellular Activity against Clinical Isolates of Neisseria gonorrhoeae from a Laboratory Collection
Julia Mallegol et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Randomized, Double-Blind, Multicenter Phase 2 Study Comparing the Efficacy and Safety of Oral Solithromycin (CEM-101) to Those of Oral Levofloxacin in the Treatment of Patients with Community-Acquired Bacterial Pneumonia
David Oldach et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Correlation of MIC value and disk inhibition zone diameters in clinical Legionella pneumophila serogroup 1 isolates
Jacob P. Bruin et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2013)
Selection of resistance at lethal and non-lethal antibiotic concentrations
Diarmaid Hughes et al.
CURRENT OPINION IN MICROBIOLOGY (2012)
Wild-type MIC distribution and epidemiological cut-off values in clinical Legionella pneumophila serogroup 1 isolates
Jacob P. Bruin et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Legionella pneumophila Sequence Type 1/Paris Pulsotype Subtyping by Spoligotyping
Christophe Ginevra et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Molecular Analysis of Antimicrobial Resistance Mechanisms in Neisseria gonorrhoeae Isolates from Ontario, Canada
Vanessa G. Allen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Pharmacokinetics of Solithromycin (CEM-101) after Single or Multiple Oral Doses and Effects of Food on Single-Dose Bioavailability in Healthy Adult Subjects
J. Gordon Still et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Binding and Action of CEM-101, a New Fluoroketolide Antibiotic That Inhibits Protein Synthesis
Beatriz Llano-Sotelo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
CEM-101 Activity against Gram-Positive Organisms
Leah N. Woosley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Antibiotic resistance in the environment: a link to the clinic?
Gerard D. Wright
CURRENT OPINION IN MICROBIOLOGY (2010)
Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates
David J. Farrell et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
New Endemic Legionella pneumophila Serogroup I Clones, Ontario, Canada
Nathalie Tijet et al.
EMERGING INFECTIOUS DISEASES (2010)
Cellular Accumulation and Pharmacodynamic Evaluation of the Intracellular Activity of CEM-101, a Novel Fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in Human THP-1 Macrophages
Sandrine Lemaire et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Multigenome analysis identifies a worldwide distributed epidemic Legionella pneumophila clone that emerged within a highly diverse species
Christel Cazalet et al.
GENOME RESEARCH (2008)
Demonstration of intrinsic efflux activity of Escherichia coli K-12 AG100 by an automated ethidium bromide method
Miguel Viveiros et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Mechanisms of Legionella pneumophila-induced interleukin-8 expression in human lung epithelial cells
Hiromitsu Teruya et al.
BMC MICROBIOLOGY (2007)
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
Lionel A. Mandell et al.
CLINICAL INFECTIOUS DISEASES (2007)
Severe Legionnaires' disease successfully treated with levofloxacin and azithromycin
M. L. Pedro-Botet et al.
JOURNAL OF CHEMOTHERAPY (2006)
Temperature-regulated formation of mycelial mat-like biofilms by Legionella pneumophila
ZY Piao et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2006)
Sampling the antibiotic resistome
VM D'Costa et al.
SCIENCE (2006)
Fluoroquinolones vs macrolides in the treatment of Legionnaires disease
A Sabrià et al.
CHEST (2005)
Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing
JE Stout et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
The genomic sequence of the accidental pathogen Legionella pneumophila
MC Chien et al.
SCIENCE (2004)
Occurrence and fate of macrolide antibiotics in wastewater treatment plants and in the Glatt Valley Watershed, Switzerland
CS McArdell et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2003)
Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study
DJ Farrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Development and mechanism of fluoroquinolone resistance in Legionella pneumophila
D Jonas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Trends in legionnaires disease, 1980-1998: Declining mortality and new patterns of diagnosis
AL Benin et al.
CLINICAL INFECTIOUS DISEASES (2002)
Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae
LK Ng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis:: An international collaborative survey
VL Yu et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Legionella and Legionnaires' disease:: 25 years of investigation
BS Fields et al.
CLINICAL MICROBIOLOGY REVIEWS (2002)
Susceptibility of Legionella species to five antibiotics and development of resistance by exposure to erythromycin, ciprofloxacin, and rifampicin
K Nielsen et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2000)
Identification of the conjugative mef gene in clinical Acinetobacter junii and Neisseria gonorrhoeae isolates
VA Luna et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
